“atopic-dermatitis” Archives

in
Entry Author Date Location
Kymera Therapeutics Unveils IPO Pitch for Protein Degradation 07/31/20 Boston
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic 05/21/20 Boston
Menlo’s Itching Drug Racks Up Two More Trial Failures, Program Ends 04/06/20 New York
Bio Roundup: Clinical Trials Paused, New MS Drug, Kallyope’s Cash & More 03/27/20 National
Bio Roundup: COVID-19 Trials, Esperion’s Approvals, NASH News & More 02/28/20 National
With Foamix Merger Weeks Away, Menlo Itching Drug Fails a Phase 2 Test 02/26/20 San Francisco
Bio Roundup: Feds Sue Gilead, Biogen Eyes China, CRISPR’d Kidneys & More 11/08/19 National
Four More Through the IPO Door as Life Science Firms Raise $465M 06/20/19 National
The Biotech IPO Queue Grows Longer as Five More Companies File 05/28/19 National
Elanco Bolsters Pet Products Pipeline With $234M Deal for Aratana 04/26/19 Indiana
Bio Roundup: Golumbeski’s Legacy, CRISPR Moratorium, Rebate Week & More 03/15/19 National
Menlo’s Drug Fails Again in Clinical Trials, This Time for Chronic Cough 10/08/18 San Francisco
Bio Roundup: Pfizer’s Prices, Novartis Cuts, Gene Therapy Guide & More 07/13/18 National
Evelo IPO Raises $85M for Microbiome Drugs in Inflammation, Cancer 05/09/18 Boston
After Strong 2017, Biotechs & Medtechs Start ’18 with Venture, IPO News 01/02/18 National
Dermira Commits $135M for Global Rights to Roche Eczema Drug 08/08/17 San Francisco
Bio Roundup: Theranos Cuts, Alnylam Stops, Nobel Eats Its Own & More 10/07/16 National
Pfizer, Moving on From Allergan, Pays $5.2B For Anacor Pharma 05/16/16 San Francisco
East Coast Biotech Roundup: Agios, Vertex, Epizyme, Celldex, & More 11/21/14 Boston
East Coast Biotech Roundup: Regeneron, Sarepta, Jounce, & More 07/11/14 Boston
Regeneron, Sanofi Drug Holds Up in Eczema Study 07/09/14 New York
Page 1 of 1